Keller RB, Mazor T, Sholl L, et al. Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer. JCO precision oncology. 2023;7:e2200342. doi:10.1200/PO.22.00342
Publications
Greten TF, Schwabe R, Bardeesy N, et al. Immunology and immunotherapy of cholangiocarcinoma. Nature reviews. Gastroenterology & hepatology. 2023. doi:10.1038/s41575-022-00741-4
Arendt ML, Sakthikumar S, Melin M, et al. PIK3CA is recurrently mutated in canine mammary tumors, similarly to in human mammary neoplasia. Scientific reports. 2023;13(1):632. doi:10.1038/s41598-023-27664-7
Group PTC, Calabrese C, Davidson NR, et al. Author Correction: Genomic basis for RNA alterations in cancer. Nature. 2023;614(7948):E37. doi:10.1038/s41586-022-05596-y
Chen Y, Lu T, Pettersson-Kymmer U, et al. Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases. Nature genetics. 2023;55(1):44-53. doi:10.1038/s41588-022-01270-1
Anchan RM, Wojdyla D, Bortoletto P, et al. A Comparative Analysis of Health-Related Quality of Life 1 Year Following Myomectomy or Uterine Artery Embolization: Findings from the COMPARE-UF Registry. Journal of women’s health (2002). 2023;32(4):423-433. doi:10.1089/jwh.2022.0133
Rheinbay E, Nielsen MM, Abascal F, et al. Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. Nature. 2023;614(7948):E40. doi:10.1038/s41586-022-05599-9
Wagner BK. Identifying type 2 diabetes risk genes by β-cell CRISPR screening. Nature genetics. 2023;55(1):4-5. doi:10.1038/s41588-022-01269-8
Taka AM, But A, Lempainen J, et al. Finnish children carrying the high-risk HLA genotype have a 45-fold increased risk of type 1 diabetes compared to peers with neutral or protective genotypes. Diabetes research and clinical practice. 2023;197:110256. doi:10.1016/j.diabres.2023.110256
Gradauskaite V, Inglebert M, Doench J, et al. LRP6 Is a Functional Receptor for Attenuated Canine Distemper Virus. mBio. 2023;14(1):e0311422. doi:10.1128/mbio.03114-22